Journal History
| 2014 | The inaugural issue was released. Journal of Cardiovascular Development and Disease was published as a quarterly journal. |
| 2018 | Journal of Cardiovascular Development and Disease was indexed in PubMed Central (PMC)—National Library of Medicine (NLM), starting with Volume 1 (Issue 1). Journal of Cardiovascular Development and Disease was indexed in Emerging Sources Citation Index (ESCI)—Web of Science (Clarivate Analytics), starting with Volume 1 (Issue 1). |
| 2020 | Journal of Cardiovascular Development and Disease was indexed in Scopus (Elsevier), starting with Volume 1 (Issue 1). Journal of Cardiovascular Development and Disease was indexed in Science Citation Index Expanded (SCIE)—Web of Science (Clarivate Analytics), starting with Volume 1 (Issue 1). |
| 2021 | Journal of Cardiovascular Development and Disease adopted a monthly publication schedule. Journal of Cardiovascular Development and Disease received its first Impact Factor (3.948). |
| 2022 | Journal of Cardiovascular Development and Disease received its 2021 Impact Factor (4.415). |
| 2023 | Journal of Cardiovascular Development and Disease received its 2022 Impact Factor (2.4). |
| 2024 | The year 2024 marked the 10th Anniversary of Journal of Cardiovascular Development and Disease. Journal of Cardiovascular Development and Disease received its 2023 Impact Factor (2.4). |
| 2025 | Journal of Cardiovascular Development and Disease received its 2024 Impact Factor (2.3), ranked 105/231 (Q2) in "Cardiac & Cardiovascular Systems". Journal of Cardiovascular Development and Disease received its 2024 CiteScore (3.7), ranked 21/77 in "General Pharmacology, Toxicology and Pharmaceutics", ranked 138/275 in "Pharmacology (Medical)". |
| 2026 | Journal of Cardiovascular Development and Disease received its 2025 Impact Factor (2.6), ranked 115/237 (Q2) in "Cardiac & Cardiovascular Systems". Journal of Cardiovascular Development and Disease received its 2025 CiteScore (4.5), ranked 19/79 (Q1) in "General Pharmacology, Toxicology and Pharmaceutics", ranked 116/278 (Q2) in "Pharmacology (Medical)". |
Editor-in-Chief
| 2014–2023 | Editor-in-Chief: Prof. Dr. Andy Wessels |
| 2023–present | Editor-in-Chief:
Prof. Dr. Thomas Brand
|
Section Editor-in-Chief
| 2023–present |
Section Editor-in-Chief: Prof. Dr. Matteo Bertini for the section on Electrophysiology and Cardiovascular Physiology |
| 2024–2026 |
Section Editor-in-Chief: Prof. Dr. Alan P. Sawchuk for the section on Stroke and Cerebrovascular Disease |
| 2024–present |
Section Editor-in-Chief: Prof. Dr. Paolo Emilio Puddu for the section on Epidemiology, Lifestyle, and Cardiovascular Health |
J. Cardiovasc. Dev. Dis. - ISSN 2308-3425